MLEC - Moolec Science SA


7.27
-0.580   -7.978%

Share volume: 14,157
Last Updated: 04-17-2026
Trading/Investment Offices: 0.06%

PREVIOUS CLOSE
CHG
CHG%

$7.85
-0.58
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
-8.44%
1 Month
-21.32%
3 Months
65.60%
6 Months
999.02%
1 Year
956.69%
2 Year
419.29%
Key data
Stock price
$7.27
P/E Ratio 
0.00
DAY RANGE
$7.25 - $7.86
EPS 
N/A
52 WEEK RANGE
$0.21 - $23.22
52 WEEK CHANGE
$956.69
MARKET CAP 
32.684 M
YIELD 
N/A
SHARES OUTSTANDING 
37.564 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
-0.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$26,238
AVERAGE 30 VOLUME 
$560,785
Company detail
CEO: Gastón Paladini
Region: US
Website: moolecscience.com
Employees: 4
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Trading/Investment Offices
Sector: Finance, Insurance, And Real Estate

Moolec Science is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas.

Recent news